Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod - Concepedia

Concepedia

Publication | Open Access

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod

DOI Full Paper Access

22

Citations

19

References

2022

Year

Rocco Capuano, Manuela Altieri, Miriana Conte, Alvino Bisecco, Alessandro d’Ambrosio, Giovanna Donnarumma, Elena Grimaldi, Nicola Coppola, Nicola Medici, Massimiliano Galdiero,

Journal of Neurology

References

	Year	Citations

Page 1